We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1726
Hecla Mining
HL
$11.2B
| $18.6K | ﹤0.01% |
3,097
-171,143
| -98% | -$944K |
2024 Q4
2 quarters
|
|
1727
Photronics
PLAB
$1.73B
| $18.5K | ﹤0.01% |
985
+179
| +22% | +$3.35K |
2024 Q4
2 quarters
|
|
1728
Rush Enterprises Class A
RUSHA
$5.2B
| $18.4K | ﹤0.01% |
+536
| New | +$18.1K |
2025 Q2
0 quarters
|
|
1729
First Merchants
FRME
$2.48B
| $17.7K | ﹤0.01% |
462
+54
| +13% | +$2K |
2024 Q4
2 quarters
|
|
1730
Commercial Vehicle Group
CVGI
$118M
| $17.5K | ﹤0.01% |
10,554
+5,050
| +92% | +$6.14K |
2023 Q4
6 quarters
|
|
1731
Douglas Elliman
DOUG
$137M
| $17.2K | ﹤0.01% |
7,427
+5,901
| +387% | +$12.6K |
2024 Q4
2 quarters
|
|
1732
Diodes
DIOD
$4.19B
| $17.2K | ﹤0.01% |
325
-100
| -24% | -$4.4K |
2016 Q4
34 quarters
|
|
1733
Old Dominion Freight Line
ODFL
$37.7B
| $17K | ﹤0.01% |
105
-18,445
| -99% | -$2.94M |
2013 Q2
48 quarters
|
|
1734
WisdomTree
WT
$3.35B
| $16.9K | ﹤0.01% |
1,464
-581
| -28% | -$5.44K |
2024 Q3
3 quarters
|
|
1735
Standard BioTools
LAB
$255M
| $16.8K | ﹤0.01% |
14,022
+14,020
| +701,000% | +$15.5K |
2024 Q3
3 quarters
|
|
1736
DELISTED
TEGNA Inc
TGNA
| $16.7K | ﹤0.01% |
999
-283
| -22% | -$4.71K |
2013 Q2
48 quarters
|
|
1737
News Corp Class B
NWS
$17.5B
| $16.6K | ﹤0.01% |
485
-6
| -1% | -$190 |
2024 Q1
5 quarters
|
|
1738
Group 1 Automotive
GPI
$2.74B
| $16.6K | ﹤0.01% |
38
-13
| -25% | -$5.46K |
2018 Q4
26 quarters
|
|
1739
DELISTED
89bio
ETNB
| $16.5K | ﹤0.01% |
1,682
-931
| -36% | -$7.71K |
2024 Q2
4 quarters
|
|
1740
Elme Communities
ELME
$156M
| $16.2K | ﹤0.01% |
+1,021
| New | +$16.2K |
2025 Q2
0 quarters
|
|
1741
KRONOS Worldwide
KRO
$854M
| $16.2K | ﹤0.01% |
2,609
| – | – |
2024 Q4
2 quarters
|
|
1742
KE Holdings
BEKE
$19.5B
| $16.2K | ﹤0.01% |
911
-2,902,928
| -100% | -$55.8M |
2023 Q1
9 quarters
|
|
1743
Vir Biotechnology
VIR
$1.92B
| $16.1K | ﹤0.01% |
3,186
-15
| -0.5% | -$80 |
2023 Q4
6 quarters
|
|
1744
DELISTED
Ventyx Biosciences
VTYX
| $16K | ﹤0.01% |
7,470
-2,025
| -21% | -$3.27K |
2025 Q1
1 quarter
|
|
1745
First Community Corp
FCCO
$307M
| $15.8K | ﹤0.01% |
650
+454
| +232% | +$10.5K |
2025 Q1
1 quarter
|
|
1746
CorVel
CRVL
$3.96B
| $15.8K | ﹤0.01% |
154
-93
| -38% | -$10.3K |
2017 Q1
33 quarters
|
|
1747
DELISTED
MidWestOne Financial Group
MOFG
| $15.6K | ﹤0.01% |
+542
| New | +$15.3K |
2025 Q2
0 quarters
|
|
1748
Finward Bancorp
FNWD
$181M
| $15.5K | ﹤0.01% |
562
+158
| +39% | +$4.67K |
2025 Q1
1 quarter
|
|
1749
Iovance Biotherapeutics
IOVA
$6.62B
| $15.5K | ﹤0.01% |
+9,016
| New | +$22.4K |
2025 Q2
0 quarters
|
|
1750
Collegium Pharmaceutical
COLL
$721M
| $15.4K | ﹤0.01% |
522
-79
| -13% | -$2.25K |
2023 Q1
9 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.